Welcome to our dedicated page for RENTOKIL INITIAL PLC /FI SEC filings (Ticker: RTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on RENTOKIL INITIAL PLC /FI's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into RENTOKIL INITIAL PLC /FI's regulatory disclosures and financial reporting.
Janus Henderson Group plc reports beneficial ownership of common stock in Rentokil Initial plc totaling 142,879,790 shares, representing approximately 5.7% of the class. The filing identifies the reporting person as an investment adviser (Type IA, HC) and discloses that certain indirect subsidiaries (including JHIUS) may be deemed beneficial owners of a portion of the position, with JHIUS shown as beneficially owning 127,751,451 shares (about 5.1% of the class).
The filing states these securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control of the issuer. A power of attorney authorizes named company employees to execute filings on Janus Henderson's behalf.
H1 2025 highlights: Revenue from continuing operations grew 3.1 % YoY to $3.36 bn (1.6 % organic). Adjusted operating profit slipped 4.5 % to $511 m, cutting margin 120 bps to 15.2 %. Adjusted PBT was $418 m (-7.8 %) and adjusted EPS 12.46 c (-11 %). Statutory PBT fell 26 % to $216 m after a $79 m increase in the termite-damage provision.
Cash & capital: Free cash flow rose 31 % to $282 m with 93 % conversion (vs 80 % guidance). Net debt climbed to $4.22 bn, or 2.8× adjusted EBITDA, largely due to bond financing and FX; liquidity headroom is $2.0 bn. Interim dividend maintained at 4.15 c.
Operating trends: North America revenue +2.0 % (organic +1.1 %) but adjusted profit -7.3 % and margin 16.9 %. International revenue +5.1 %, adjusted profit +4.6 %, margin steady at 19.3 %. Group organic growth improved in Q2, with North America organic growth 1.4 % versus 0.7 % in Q1. Integration of Terminix continues; ~$100 m cost-reduction target and >20 % NA margin post-2026 reiterated. FY-25 outlook and technical guidance unchanged.
On 24 Jul 2025 sovereign wealth fund GIC Private Limited crossed a disclosure threshold in Rentokil Initial plc, triggering this Form 6-K/TR-1 major-holdings notice. GIC now controls 6.494659 % of Rentokil’s voting rights, equal to 164.06 million votes. The stake consists of 5.940639 % (150.06 m votes) held via ordinary shares and 0.554020 % (13.99 m votes) linked to security-lending arrangements.
The change is primarily a reclassification of part of the holding as “security lending” rather than a meaningful purchase or sale; the previously reported total was 6.500133 %. No financial results, guidance or operational updates are included. The filing, dated 28 Jul 2025, fulfils UK Disclosure & Transparency Rule 5 obligations and has limited direct impact on Rentokil’s fundamentals.